Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kenji Kufukihara"'
Autor:
Haruhiko Motegi, Kenji Kufukihara, Koji Sekiguchi, Satoshi Kitagawa, Junichi Hata, Hirokazu Fujiwara, Masahiro Jinzaki, Hideyuki Okano, Masaya Nakamura, Jin Nakahara
Publikováno v:
Wednesday, April 26.
Autor:
Kenji Kufukihara
Publikováno v:
Clinical and Experimental Neuroimmunology. 12:228-237
Multiple sclerosis (MS) has long been considered a T-cell-mediated autoimmune disease of the central nervous system. However, newer evidence shows that B cells play a crucial role in the pathogenesis of MS via antibody production, antigen presentatio
Autor:
Kenji, Kufukihara, Jin, Nakahara
Publikováno v:
Brain and nerve = Shinkei kenkyu no shinpo. 73(5)
Primary progressive multiple sclerosis (PPMS) is a chronic inflammatory disease of the central nervous system that leads to demyelination and neurodegeneration. PPMS is characterized by a gradual accumulation of disabilities that may occur from the i
Autor:
Yurika Watanabe, Jin Nakahara, Koutaro Takamatsu, Yukio Ando, Takashi Inagaki, Shigeaki Suzuki, Kenji Kufukihara, Shunya Nakane
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports
Scientific Reports
The purposes of the present study were to identify anti-striational antibodies in myasthenia gravis (MG) patients with myositis and/or myocarditis using a combination of cell-based assays and flow cytometry (cytometric cell-based assays) and to descr
Autor:
Kenji, Kufukihara, Jin, Nakahara
Publikováno v:
Brain and nerve = Shinkei kenkyu no shinpo. 72(4)
The diagnosis of multiple sclerosis (MS) relies on the demonstration of disease dissemination in space and time, and the exclusion of other neurological disorders. However, it is often difficult to exclude alternative diagnoses with a single MRI exam
Autor:
Kenji, Kufukihara, Jin, Nakahara
Publikováno v:
Brain and nerve = Shinkei kenkyu no shinpo. 72(1)
Treatments for multiple sclerosis have improved dramatically over the last 20 years. These treatments help to reduce relapses and prevent progression of neurodegeneration and physical disability. Other clinical trials on remyelination therapies for m
Autor:
Jin, Nakahara, Laura, Tomaske, Kodai, Kume, Tadayuki, Takata, Masaki, Kamada, Kazushi, Deguchi, Kenji, Kufukihara, Ruth, Schneider, Ralf, Gold, Ilya, Ayzenberg
Publikováno v:
Neurology® Neuroimmunology & Neuroinflammation
\(\bf Objective\) To report the course of 3 recent Japanese and European cases of fingolimod-associated progressive multifocal leukoencephalopathy (PML) and to analyze its risk factors and increased incidence in Japan. \(\bf Methods\) Case series and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9bc26373d5d653e3393129a951175b5b
https://hss-opus.ub.ruhr-uni-bochum.de/opus4/files/7113/AyzenbergIlya1.pdf
https://hss-opus.ub.ruhr-uni-bochum.de/opus4/files/7113/AyzenbergIlya1.pdf
Autor:
Kenji Kufukihara, Koichi Oki, Satoshi Yamada, Takenori Akiyama, Norihiro Suzuki, Mamoru Shibata, Kazunari Yoshida, Mayuko Osaka
Publikováno v:
Journal of the Neurological Sciences. 349:260-261
• Triptans may be effective in alleviating headache attributable to dural arteriovenous fistula involving the cavernous sinus.